PFG Investments’s Aquestive Therapeutics AQST Stock Holding History

PFG Investments’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$89K	Sell	21,401 -9,700	-31%	-$40.8K	﹤0.01%	1239
2026 Q1	$129K	Sell	31,101 -3,700	-11%	-$15K	0.01%	1113
2025 Q4	$225K	Sell	34,801 -3,900	-10%	-$24.3K	0.01%	960
2025 Q3	$216K	Sell	38,701 -8,000	-17%	-$34.6K	0.01%	932
2025 Q2	$155K	Buy	46,701 +1,000	+2%	+$2.87K	0.01%	951
2025 Q1	$133K	Sell	45,701 -2,999	-6%	-$9.08K	0.01%	921
2024 Q4	$173K	Buy	48,700 +500	+1%	+$2.31K	0.01%	919
2024 Q3	$240K	Sell	48,200 -10,800	-18%	-$42K	0.02%	819
2024 Q2	$153K	Buy	59,000 +11,000	+23%	+$36.7K	0.01%	849
2024 Q1	$204K	Buy	+48,000	New	+$160K	0.01%	904

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

PFG Investments's AQST Position: Q2 2026 in Review

PFG Investments reduced its Aquestive Therapeutics (AQST) stake by 31% in Q2 2026, selling an estimated $40.8K and leaving 21,401 shares worth $89K. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

PFG Investments first reported a position in AQST in Q1 2024 and has held it in 10 quarters since. The position peaked at $240K in Q3 2024. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

PFG Investments held 21,401 shares of Aquestive Therapeutics worth $89K as of Q2 2026.
PFG Investments sold 9,700 Aquestive Therapeutics shares in Q2 2026, an estimated $40.8K.
Aquestive Therapeutics made up ﹤0.01% of PFG Investments's portfolio in Q2 2026, its #1239 holding.
PFG Investments first reported a position in Aquestive Therapeutics in Q1 2024 and has held it in 10 quarters since.
PFG Investments's Aquestive Therapeutics position peaked at $240K in Q3 2024.
184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.